BR9407813A - Nucleases de staphylococcus recombinantes e seu uso na limitação da sobrevivencia de microorganismos elaborados por engenharia genética - Google Patents

Nucleases de staphylococcus recombinantes e seu uso na limitação da sobrevivencia de microorganismos elaborados por engenharia genética

Info

Publication number
BR9407813A
BR9407813A BR9407813A BR9407813A BR9407813A BR 9407813 A BR9407813 A BR 9407813A BR 9407813 A BR9407813 A BR 9407813A BR 9407813 A BR9407813 A BR 9407813A BR 9407813 A BR9407813 A BR 9407813A
Authority
BR
Brazil
Prior art keywords
nucleases
survival
limiting
genetic engineering
recombinant staphylococcus
Prior art date
Application number
BR9407813A
Other languages
English (en)
Inventor
Soren Molin
Michael Givskov
Claus Sternberg Kristensen
Asim K Bej
Leo Eberl
Original Assignee
Gx Biosystems As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gx Biosystems As filed Critical Gx Biosystems As
Publication of BR9407813A publication Critical patent/BR9407813A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/32—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
    • C07K14/325—Bacillus thuringiensis crystal peptides, i.e. delta-endotoxins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases RNAses, DNAses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BR9407813A 1993-10-13 1994-10-12 Nucleases de staphylococcus recombinantes e seu uso na limitação da sobrevivencia de microorganismos elaborados por engenharia genética BR9407813A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13566593A 1993-10-13 1993-10-13
PCT/DK1994/000381 WO1995010614A1 (en) 1993-10-13 1994-10-12 Recombinant staphylococcal nucleases and their use in limiting the survival of genetically engineered microorganisms

Publications (1)

Publication Number Publication Date
BR9407813A true BR9407813A (pt) 1997-05-06

Family

ID=22469101

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9407813A BR9407813A (pt) 1993-10-13 1994-10-12 Nucleases de staphylococcus recombinantes e seu uso na limitação da sobrevivencia de microorganismos elaborados por engenharia genética

Country Status (5)

Country Link
AU (1) AU7853094A (pt)
BR (1) BR9407813A (pt)
CA (1) CA2173751A1 (pt)
NZ (1) NZ274482A (pt)
WO (1) WO1995010614A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA00009561A (es) 1998-03-30 2002-08-06 Metabolix Inc Cepas microbianas y procesos para la fabricacion de biomateriales.
DK1075512T3 (da) 1998-05-07 2010-06-07 Univ Bruxelles Cytotoxinbaseret biologisk indkapsling
US7780961B2 (en) 2001-05-03 2010-08-24 Actogenix N.V. Self-containing Lactococcus strain
ATE462779T1 (de) * 2001-07-11 2010-04-15 Lubitz Werner Prof Dr Nukleinsäurefreie ghost zusammensetzungen
US6946267B2 (en) 2002-03-13 2005-09-20 Dr. Chip Biotechnology Inc. Method for detecting Staphylococcus aureus
AU2003250250B2 (en) 2002-06-19 2008-02-14 Intrexon Actobiotics Nv Methods and means to promote gut absorption
US8748126B2 (en) 2005-11-29 2014-06-10 Actogenix N.V. Induction of mucosal tolerance to antigens
BRPI0807857A2 (pt) 2007-01-25 2014-05-27 Actogenix Nv Tratamento de doença imune por meio de distribuição através da mucosa de antígenos.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE107697T1 (de) * 1986-03-26 1994-07-15 Genexpress Aps Biologische eindämmung.
WO1988009821A1 (en) * 1987-06-12 1988-12-15 Massachusetts Institute Of Technology Coryneform expression and secretion system
ATE162220T1 (de) * 1992-04-06 1998-01-15 Gx Biosystems As Eine methode zur einschränkung des uberlebens gentechnologisch hergestellter mikroorganismen in ihrer umgebung

Also Published As

Publication number Publication date
WO1995010614A1 (en) 1995-04-20
AU7853094A (en) 1995-05-04
CA2173751A1 (en) 1995-04-20
NZ274482A (en) 1997-09-22

Similar Documents

Publication Publication Date Title
MX9204517A (es) Material esponjoso formado esencialmente por acido hialuronico o sus derivados, y su uso en microcirugia.
DE69421588D1 (de) Isolatore
DK0630901T3 (da) Silaner med hydrofile grupper, deres fremstilling og deres anvendelse som tensider i vandige medier
DE69433168D1 (de) In vitro vermehrung von stammzellen
ATE476495T1 (de) Bazillus thuringiensis und dessen insektizide proteine
ITMI920042A0 (it) Batteri sporgenti e loro impiego come probiotici
BR9407813A (pt) Nucleases de staphylococcus recombinantes e seu uso na limitação da sobrevivencia de microorganismos elaborados por engenharia genética
ATE75752T1 (de) Antibiotikum.
MX9101035A (es) Quinazolinonas biologicamente activas y composicion farmaceutica que las contiene
EP0334679A3 (en) Improvements in or relating to the inactivation of infectious agents
DE59102459D1 (de) Blei-Zink-Borosilikatglas und Verwendung des Glases.
ITMI930124A0 (it) Mobile e struttura modulare in particolare per l'arredamento di spazi espositivi
PL311815A1 (en) Plants resistant to viral infections
FI960076A (fi) Uudet (1-heteroatsolyyli-1-heterosyklyyli) alkaanijohdannaiset ja niiden käyttö hermostoa suojaavina aineina
DE58906436D1 (de) Konzentrierte und flüssige wasserhaltige Tensidzusammensetzung und deren Verwendung.
NO971548D0 (no) Fleksible og töyelige absorberende gjenstander og deres fastgjöring til undertöy
DE59407311D1 (de) Leukoindigo-präparationen in granulatform
ITMI932073A1 (it) Derivati di tioalchiltio carbacefalosporina e loro uso come antibiotici
FI953811A (fi) Lasilevyjen kuljettaminen ja muotoilu
FI945114A (fi) Tsymosiini-geenin kloonaus ja tsymosiinin käyttö virvoitusjuomissa
GB2281961B (en) Improvements in or relating to the movement of members
BR7301861U (pt) Aperfeiçoamento de ordem construtivo-operacional introduzido na concepção de tijolos
DE3851257D1 (de) Azyliertes Derivat von Superoxid-Dismutase und dieses enthaltende Zusammensetzung.
BR7300019U (pt) Garfo dianteiro com suspensão para cadeira de rodas
LT2473B (lt) Pramoniniu nutekamuju vandenu biologinio valymo budas

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Free format text: APOVIA AG (DE)

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements
B15K Others concerning applications: alteration of classification

Ipc: C12N 15/00 (2006.01), C07K 14/325 (2006.0